Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy
Launched by DEPARTMENT OF MEDICAL SERVICES MINISTRY OF PUBLIC HEALTH OF THAILAND · Aug 17, 2018
Trial Information
Current as of May 05, 2025
Completed
Keywords
ClinConnect Summary
Research design Randomized double-blinded placebo-controlled trial. The investigators who assess the outcomes and the participants do not know Misoprostal group or control group. The patients are given the random concealed envelop which contains Misoprostal or placebo to take before hysteroscopy. Surgeon and the investigator whom assess patients do not know group allocation.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Premenopausal women
- • 2. Patients have following indication for diagnosis hysteroscopy
- • Abnormal uterine bleeding
- • Unexplained infertility
- • Recurrent pregnancy loss
- • Chronic pelvic pain
- • Late postpartum hemorrhage
- • 3. Patients provided written informed consent
- Exclusion Criteria:
- • 1. Postmenopausal women
- • 2. Patients who have contraindication for Misoprostal as following
- • Allergic to Misoprostal
- • Medical illnesses such as cardiovascular diseases, Asthma, Renal disease
- • 3. Patients who have contraindication for Hysteroscopoy as following
- • Pregnant women
- • Pelvic inflammatory disease
- • Infection at cervix and vagina
- • Cervical cancer
About Department Of Medical Services Ministry Of Public Health Of Thailand
The Department of Medical Services, under the Ministry of Public Health of Thailand, is dedicated to advancing healthcare through rigorous clinical research and innovative medical practices. As a key sponsor of clinical trials, the department aims to enhance public health outcomes by evaluating new treatments, improving healthcare delivery, and ensuring the safety and efficacy of medical interventions. With a commitment to ethical standards and scientific integrity, the department collaborates with various stakeholders to address critical health challenges and promote evidence-based practices within the Thai healthcare system.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangkok, , Thailand
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials